FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an oral composition applicable for treating radiation- or chemotherapy-induced oral mucositis and containing active components: a) glycine, b) proline and optionally c) a natural or synthetic film-forming polymer, and/or d) lysine, and/or e) leucine.
EFFECT: invention provides creating an agent having a considerable accelerating action on wound healing, promoting fast and effective pain relief.
6 cl, 2 tbl
